October 20-23, 2016
Boston Marriott Copley Place
Boston, Massachusetts
Conference Co-chairpersons
James P. Allison, The University of Texas MD Anderson Cancer Center, Houston, Texas
Pamela S. Ohashi, Princess Margaret Cancer Centre, Toronto, ON, Canada
Antoni Ribas, UCLA Medical Center, Los Angeles, California
Ton Schumacher, Netherlands Cancer Institute, Amsterdam, The Netherlands
A hallmark of this AACR immunology series is the integration of several sub-disciplines of cancer immunology and immunotherapy, with a broad focus on strategies to harness the immune system for the treatment and prevention of different cancers. Leaders in the field will present their latest work and provide critical updates on our deepening understanding of the immune response towards cancer. This Special Conference will also provide a unique opportunity for the authors of highly rated abstracts to present their work to an audience of researchers from around the world. Ample time will be provided for the stimulating discussions that are necessary to further the scientific and translational goals of the field. As the sixth in the series, this conference will continue to provide a forum for the effective exchange of ideas between basic cancer immunologists, non-immunologists and clinical oncologists, from academia to industry.
Supporters
Bristol-Myers Squibb Genentech Idera Pharmaceuticals Janssen Lilly Oncology Pfizer
|
Professional Education Grants
AbbVie Amgen AstraZeneca/MedImmune Celgene Genentech Gilead Merck Pfizer |
Award Supporters
The Parker Institute for Cancer Immunotherapy Bristol-Myers Squibb Genentech
|
Continuing Medical Education Activity AMA PRA Category 1 CreditsTM available
#AACRtii16